Anticancer agents that counteract tumor glycolysis

Area of Science:

• Oncology
• Cancer Metabolism
• Biochemistry

Background:

• Cancer is characterized by cellular heterogeneity and an overactive metabolism to support growth and invasiveness.
• High tumor proliferation leads to oxygen-deficient regions, necessitating reliance on glycolysis (Warburg effect).
• The Warburg effect is a key adaptation supporting aggressive and metastatic cancer phenotypes.

Purpose of the Study:

• To explore the concept of cancer as a metabolic disease.
• To review antiglycolytic agents as potential cancer therapeutics.
• To discuss exploiting tumor cell glycolysis for targeted cancer therapy.

Main Methods:

• Review of scientific literature on cancer metabolism and antiglycolytic agents.
• Analysis of the Warburg effect as a fundamental cancer adaptation.
• Evaluation of glycolytic enzymes and transporters as therapeutic targets.

Main Results:

• Tumor cells exhibit a pronounced dependence on glycolysis, even in the presence of oxygen.
• Antiglycolytic agents targeting tumor cell metabolism show therapeutic potential.
• Exploiting the hyperbolic addiction of cancer cells to glycolysis may lead to selective therapies.

Conclusions:

• Cancer can be viewed as a metabolic disease with the Warburg effect as a central feature.
• Targeting tumor glycolysis offers a viable strategy for developing novel anticancer drugs.
• Exploiting cancer's metabolic vulnerabilities may yield effective treatments with minimal toxicity.